Posted on 8 October 2018
In a new report, 'Framework for value assessment of new antimicrobials: Implications of alternative funding arrangements for NICE Appraisal', CHE authors have investigated the ways in which the value of new antimicrobial drugs could be assessed to help the NHS decide how much should be paid for them. Read more
Full report available to read here.